SHC sunshine heart, inc.

C-Pulse Worth more than Facebook, page-2

  1. 1,224 Posts.
    I do hope so.

    Why the poison pill 2 years ago ? . shows that they knew they are a target.
    taking it to fda approval without a buyout / partnership
    in this time , multiple markets are open for cpulse2
    cpulse 2 development
    last offering was 10.5 , reason we fell from these highs was the slow enrollment trial start.
    the pause ofcourse was a kick in the balls and the time it took for reactivation took us from 4s to 1
    has the technology changed ? is their a competitor ? no

    finance situation / enrollments

    finance : debt ammended . 8 months of cash ? why would svb agree unless they know something is in the offing. the company has 2 options , major dilution at these levels ( they lose out the most ) or a partnership or us distribution rights or a license deal. that would give us enough money to last 2016.
    have an offering of 6-7m shares when the stock is $6-10

    enrollments : 40 sites soon to be all activated. the only way is up

    cpulse2 : talks with the fda to fast track approval

    -----------------------------------------------------------------------------------------------------------

    but the questions are

    1- why are we at $1 and no major buying
    2- why is the company silent 3 weeks after ceo sudden departure
    3- how are we valued at $24m ?
    4- till when will we have positive news and the stock drops ( debt ammendment )
    5- 91% down since nasdaq inception.

    are we the only ones who see the potential ?
    is there something hidden which explains the death of the stock

    we sound like a broken cd , but the more these questions are left un answered , the further we will drop
    the more we drop , the harder it will be for the company to achieve its goals.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.